ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,992, issued on June 17, was assigned to Emory University (Atlanta) and The Scripps Research Institute (La Jolla, Calif.).

"Ebola virus antibodies and binding agents derived therefrom" was invented by Rafi Ahmed (Atlanta), Carl Davis (Atlanta) and Erica Ollmann Saphire (Solana Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to antibodies and antigen binding fragments that specifically bind Ebola virus particles. In certain embodiments, the antibodies and fragments are capable of treating or preventing an Ebola viral infection. In certain embodiments, the antibodies and antigen binding fragments are also contemplat...